A Study of LY3090106 in Healthy Participants and Participants With Rheumatoid Arthritis (RA)

NCT01925157 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: LY3090106 - SQ
BIOLOGICAL: LY3090106 - IV
BIOLOGICAL: Placebo - SQ

Sponsor

Eli Lilly and Company